Epigenetic clock analyses of cellular senescence and ageing.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study on cultured cells without human clinical data.
PubMed 26885756 · doi:10.18632/oncotarget.7383
What was done
The authors analyzed biological aging in cell models using a DNA methylation-based epigenetic clock. Primary cells, telomerase-expressing cells, and oncogene-expressing cells sharing the same genetic background were examined under replicative senescence, oncogene-induced senescence, DNA damage-induced senescence, and standard culture of telomerase-immortalized cells.
What was found
No quantitative values, effect sizes, or confidence intervals are reported in the abstract. Replicative senescence and oncogene-induced senescence were accompanied by cellular epigenetic aging, whereas DNA damage-induced senescence was not. Telomerase-immortalized cells demonstrated epigenetic aging during culture without senescence inducers or DNA-damaging agents.
Why it matters
The study demonstrates that cellular epigenetic aging can be experimentally uncoupled from cellular senescence, telomere length, and DNA damage response activation.
Limits
This is an in vitro bench study on cultured cell lines, limiting direct translation to in vivo human tissue aging. The abstract does not provide exact sample sizes, cell types, or quantitative data points.
Cited by
- supports Radiation-induced cellular senescence does not accelerate epigenetic clocks.
- supports Immortalizing a cell by overexpressing TERT (telomerase reverse transcriptase) does not stop epigenetic aging, and its epigenetic age continues to increase with passaging.